Labcorp Holdings Inc.

LH ·Healthcare, Medical Care Facilities, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $876.5M $746.0M $418.0M $1.28B $2.38B $1.56B $823.8M $883.7M
Depreciation & Amortization $681.1M $643.5M $577.3M $537.2M $577.0M $624.7M $577.2M $552.1M
Depreciation — $387.1M $357.5M $343.6M $347.5M $349.3M — —
Amortization $280.0M $256.4M $219.8M $193.6M $229.5M $275.4M $243.2M $231.7M
Stock-Based Compensation $125.8M $116.7M $128.7M $116.8M $132.9M $111.7M $107.0M $91.6M
Net Cash from Operating Activities $1.64B $1.59B $1.33B $1.96B $3.11B $2.14B $1.44B $1.31B
Investing Activities
Capital Expenditures $434.5M $489.9M $453.6M $429.3M $421.5M $381.7M $400.2M $379.8M
Business Acquisitions $582.0M $839.0M $671.5M $1.16B $496.9M $267.6M $876.0M $117.8M
Net Cash from Investing Activities $-1.19B $-1.37B $-1.17B $-1.65B $-884.6M $-643.2M $-1.28B $206.7M
Financing Activities
Dividends Paid $240.7M $243.1M $254.0M $195.2M — — — —
Stock Repurchases $450.0M $250.1M $1.00B $1.10B $1.67B $100.0M $450.0M $700.0M
Net Cash from Financing Activities $-1.46B $779.9M $-59.3M $-1.32B $-2.07B $-517.4M $-252.7M $-1.39B
Net Change in Cash $-986.4M $981.9M $106.8M $-1.04B $151.9M $983.3M $-89.3M $110.2M
Free Cash Flow $1.21B $1.10B $874.1M $1.53B $2.69B $1.75B $1.04B $925.6M
← Newer Page 1 of 3 Older →